Schedule 13D ownership disclosure
SYNTA PHARMACEUTICALS CORP
Security class unavailable · CUSIP: 87162T206
Event date: 2014-04-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-14-002710
- Form type
- SC 13D
- Filer
- CxSynta LLC
- CIK
- CIK 1388171
- Filed
- Apr 23, 2014
- Reporting period
- Apr 11, 2014
- Description
- Schedule 13D beneficial ownership